EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and Validation of a Machine Learning–Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction–Associated Fatty Liver Disease

Li-Huan Wang

Turkish Journal of Gastroenterology · 2026

DOI: 10.5152/tjg.2026.25611 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Turkish Journal of Gastroenterology, 2026. Verfasst von Li-Huan Wang. Beteiligte Einrichtung: Department of Infectious Diseases, Jiashan County First People's Hospital, Jiashan, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease, Machine Learning, Metabolic Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Metabolic dysfunction–associated fatty liver disease (MAFLD) is strongly associated with increased cardiovascular disease (CVD) risk. However, traditional cardiovascular risk assessment tools may inadequately capture the complex pathophysiology linking hepatic and CVD in MAFLD patients. This study aimed to develop and validate machine learning models to predict CVD risk in MAFLD patients. Materials and Methods: This cross-sectional study analyzed NHANES 2017-2023 data, with participants randomly split into training (70%) and validation (30%) sets. Results: A total of 6828 adults with MAFLD were included (13.1% with prevalent CVD). Least Absolute Shrinkage and Selection Operator regression identified 14 key predictors, with age, nonalcoholic fatty liver disease Fibrosis Score (NFS), and albumin emerging as the most influential. Critically, liver-specific markers (NFS: mean |SHAP| = 0.0299; albumin: 0.0289) demonstrated superior predictive capacity compared to traditional cardiovascular risk factors (hypertension: 0.0145; diabetes: 0.0107; smoking: 0.0035). SHapley Additive exPlanations analysis revealed that older age, higher NFS (particularly > −1.0), and lower albümin (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseMachine LearningMetabolic DiseasesHumansFemaleCross-Sectional StudiesMaleMiddle AgedPredictive Learning ModelsAdultRisk AssessmentBiomarkersNutrition SurveysHeart Disease Risk FactorsRisk FactorsAgedLiver Cirrhosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Infectious Diseases, Jiashan County First People's Hospital, Jiashan, China.

Zitieren

APA

Wang, L. H. (2026). Development and Validation of a Machine Learning–Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction–Associated Fatty Liver Disease. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2026.25611

Vancouver

Wang LH. Development and Validation of a Machine Learning–Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction–Associated Fatty Liver Disease. Turkish Journal of Gastroenterology. 2026. doi:10.5152/tjg.2026.25611

BibTeX
@article{Wang2026,
  author = {Wang, Li-Huan},
  title = {Development and Validation of a Machine Learning–Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction–Associated Fatty Liver Disease},
  journal = {Turkish Journal of Gastroenterology},
  year = {2026},
  doi = {10.5152/tjg.2026.25611}
}
Kostenlos starten →